USBC Stock Overview

Engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. More details

USBC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($41)

Latest financial reports are more than a year old

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

US BioTec, Inc. Competitors

DermTech

OTCPK:DMTK.Q

US$35.0

eFFECTOR Therapeutics

OTCPK:EFTR

US$940.0

MJ Holdings

OTCPK:MJNE

US$58.0

Molecular Templates

OTCPK:MTEM

US$17.1k

Price History & Performance

Summary of share price highs, lows and changes for US BioTec
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.0001
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	9,900.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	USBC	US Biotechs	US Market
7D	n/a	-0.2%	3.2%
1Y	n/a	-7.0%	24.2%

Return vs Industry: Insufficient data to determine how USBC performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how USBC performed against the US Market.

Price Volatility

Is USBC's price volatile compared to industry and market?
USBC volatility
USBC Average Weekly Movement	n/a
Biotechs Industry Average Movement	11.2%
Market Average Movement	6.5%
10% most volatile stocks in US Market	18.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: USBC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine USBC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Jimmy Joyner	n/a

US BioTec, Inc. engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. Its product portfolio consists of approximately 30 products, which stimulate plants that produce crops; correct microbial and mineral problems present in soils; and rehabilitate the soil ecosystem by breaking down the residual build-up of toxic insecticides, herbicides, fungicides, and synthetic fertilizers. The company provides its products for agriculture, commercial turf industry, forestry, golf courses, professional landscapers, nurseries and mass market retail lawn, and garden markets.

US BioTec, Inc. Fundamentals Summary

How do US BioTec's earnings and revenue compare to its market cap?
USBC fundamental statistics
Market cap	US$41.00
Earnings (TTM)	-US$376.31k
Revenue (TTM)	US$1.64m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is USBC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
USBC income statement (TTM)
Revenue	US$1.64m
Cost of Revenue	US$1.33m
Gross Profit	US$300.98k
Other Expenses	US$677.29k
Earnings	-US$376.31k

Last Reported Earnings

Dec 31, 2005

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did USBC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/20 09:36
End of Day Share Price	2025/01/17 00:00
Earnings	2005/12/31
Annual Earnings	2005/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

US BioTec, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution